Charming Medical Ltd (MCTA)

Charming Medical Ltd is a Hong Kong-based company whose subsidiaries provide beauty, wellness, and postpartum care services under the Beauty Lab brand. Its business includes therapy and care offerings such as womb-warming treatment, pelvic detox services, agarwood moxibustion, prenatal massage inspired by traditional Chinese medicine, and Indonesian-style abdominal binding. The company also sells TCM-inspired supplements and beauty products, including herbal care patches, intimate wash products, moisturizing cleansers, and scalp care items. In addition, Charming Medical provides consultancy and training services to other beauty salons, massage centers, and similar institutions, covering therapy techniques and dietary guidance. The company operates wellness centres and was founded in 2016. Its headquarters are in Causeway Bay, Hong Kong.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-MCTA
$16.94
-42.3% Downside
Overvalued
Not available
Not available
Fair
0.0%
97.3x
104.9x
504.3 M
497.6 M
0.2%
28.1%
7.1
6,868.1%
Valuation • Fair Value

Charming Medical Ltd (NASDAQ-MCTA) Fair Value by Valuation Model

Review the available estimates for Charming Medical Ltd (NASDAQ-MCTA), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$16.94

Estimated downside of 42.3% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$14.63

Discounted cash flow valuation reference.

Comps Fair Value

$18.09

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Charming Medical Ltd (NASDAQ-MCTA) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Charming Medical Ltd (NASDAQ-MCTA)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

4.808 M

Current operating scale indicator.

Revenue Forecast

4.808 M

Forward revenue estimate.

EBITDA

324.583 K

Current operating profitability reference.

EBITDA Forecast

834.759 K

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Charming Medical Ltd (NASDAQ-MCTA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Charming Medical Ltd (NASDAQ-MCTA)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-2.58

No elevated caution signal from this screen.

Altman Z-Score

7.1

Relatively strong balance-sheet zone.

FCF / Net Income

6,868.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Charming Medical Ltd (NASDAQ-MCTA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Charming Medical Ltd (NASDAQ-MCTA)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Charming Medical Ltd (NASDAQ-MCTA). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Charming Medical Ltd (NASDAQ-MCTA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Charming Medical Ltd (NASDAQ-MCTA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Charming Medical Ltd (NASDAQ-MCTA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Charming Medical Ltd (NASDAQ-MCTA) Stock FAQ

Data-supported answers about Charming Medical Ltd (NASDAQ-MCTA), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$16.94
Estimated downside 42.3%
Valuation Rating
Overvalued
Estimated downside of 42.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Charming Medical Ltd (NASDAQ-MCTA) is $16.94. This implies an estimated downside of 42.3% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 42.3% versus the current market price.

The current financial health read for Charming Medical Ltd (NASDAQ-MCTA) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Charming Medical Ltd (NASDAQ-MCTA).

The current market capitalization listed for Charming Medical Ltd is 504.3 M.

The current enterprise value listed for Charming Medical Ltd is 497.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Charming Medical Ltd is NASDAQ-MCTA, and the stock is listed on NASDAQ.

Charming Medical Ltd (NASDAQ-MCTA) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Charming Medical Ltd is 0.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Charming Medical Ltd is 28.1%. Free float helps investors understand how much of the share base is available for public trading.